US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 5.130
  • +0.120+2.40%
Close Mar 28 16:00 ET
  • 5.060
  • -0.070-1.36%
Post 19:41 ET
249.58MMarket Cap-3828P/E (TTM)

Elevation Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-57.34%40.34M
-57.13%7.95M
-71.66%10.92M
-51.11%9.83M
-32.99%11.64M
195.04%94.55M
92.61%18.54M
213.85%38.53M
297.57%20.11M
241.49%17.37M
Selling and administrative expenses
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
87.34%15.83M
19.56%4.04M
40.68%4.19M
233.01%3.81M
298.42%3.79M
-General and administrative expense
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
87.34%15.83M
19.56%4.04M
40.68%4.19M
233.01%3.81M
298.42%3.79M
Research and development costs
-67.69%25.43M
-67.65%4.69M
-78.39%7.42M
-63.01%6.03M
-46.28%7.29M
233.62%78.72M
132.07%14.5M
269.33%34.34M
316.45%16.3M
228.37%13.58M
Operating profit
57.34%-40.34M
57.13%-7.95M
71.66%-10.92M
51.11%-9.83M
32.99%-11.64M
-195.04%-94.55M
-92.61%-18.54M
-213.85%-38.53M
-297.57%-20.11M
-241.49%-17.37M
Net non-operating interest income expense
40.00%-300K
-500K
Non-operating interest income
290.00%3.9M
----
----
----
----
--1M
----
----
----
----
Non-operating interest expense
180.00%4.2M
----
----
----
----
--1.5M
----
----
----
----
Other net income (expense)
-83,833.33%-5.04M
1,680.00%356K
196.41%295K
-244.92%-271K
-5,923.66%-5.42M
-185.71%-6K
900.00%20K
-3,160.00%-306K
187K
1,960.00%93K
Special income (charges)
---5.11M
--0
--0
--0
---5.11M
--0
--0
--0
--0
--0
-Less:Restructuring and merger&acquisition
--5.11M
--0
--0
--0
--5.11M
--0
--0
--0
--0
--0
Other non- operating income (expenses)
1,283.33%71K
1,680.00%356K
196.41%295K
-244.92%-271K
-432.26%-309K
-185.71%-6K
900.00%20K
-3,160.00%-306K
--187K
1,960.00%93K
Income before tax
51.95%-45.67M
58.51%-7.89M
72.64%-10.63M
49.29%-10.11M
1.28%-17.05M
-196.69%-95.06M
-97.64%-19.02M
-216.60%-38.84M
-293.87%-19.93M
-239.32%-17.28M
Income tax
20.00%30K
-64.00%9K
11K
5K
5K
25K
25K
0
0
0
Net income
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
-293.87%-19.93M
-239.32%-17.28M
Net income continuous Operations
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
-293.87%-19.93M
-239.32%-17.28M
Minority interest income
Net income attributable to the parent company
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
-293.87%-19.93M
-239.32%-17.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
-293.87%-19.93M
-239.32%-17.28M
Basic earnings per share
67.24%-1.34
84.15%-0.13
85.03%-0.25
56.98%-0.37
2.70%-0.72
-54.92%-4.09
-97.76%-0.82
-215.09%-1.67
82.23%-0.86
-231.73%-0.74
Diluted earnings per share
67.24%-1.34
84.15%-0.13
85.03%-0.25
56.98%-0.37
2.70%-0.72
-54.92%-4.09
-97.76%-0.82
-215.09%-1.67
82.23%-0.86
-231.73%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -57.34%40.34M-57.13%7.95M-71.66%10.92M-51.11%9.83M-32.99%11.64M195.04%94.55M92.61%18.54M213.85%38.53M297.57%20.11M241.49%17.37M
Selling and administrative expenses -5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M87.34%15.83M19.56%4.04M40.68%4.19M233.01%3.81M298.42%3.79M
-General and administrative expense -5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M87.34%15.83M19.56%4.04M40.68%4.19M233.01%3.81M298.42%3.79M
Research and development costs -67.69%25.43M-67.65%4.69M-78.39%7.42M-63.01%6.03M-46.28%7.29M233.62%78.72M132.07%14.5M269.33%34.34M316.45%16.3M228.37%13.58M
Operating profit 57.34%-40.34M57.13%-7.95M71.66%-10.92M51.11%-9.83M32.99%-11.64M-195.04%-94.55M-92.61%-18.54M-213.85%-38.53M-297.57%-20.11M-241.49%-17.37M
Net non-operating interest income expense 40.00%-300K-500K
Non-operating interest income 290.00%3.9M------------------1M----------------
Non-operating interest expense 180.00%4.2M------------------1.5M----------------
Other net income (expense) -83,833.33%-5.04M1,680.00%356K196.41%295K-244.92%-271K-5,923.66%-5.42M-185.71%-6K900.00%20K-3,160.00%-306K187K1,960.00%93K
Special income (charges) ---5.11M--0--0--0---5.11M--0--0--0--0--0
-Less:Restructuring and merger&acquisition --5.11M--0--0--0--5.11M--0--0--0--0--0
Other non- operating income (expenses) 1,283.33%71K1,680.00%356K196.41%295K-244.92%-271K-432.26%-309K-185.71%-6K900.00%20K-3,160.00%-306K--187K1,960.00%93K
Income before tax 51.95%-45.67M58.51%-7.89M72.64%-10.63M49.29%-10.11M1.28%-17.05M-196.69%-95.06M-97.64%-19.02M-216.60%-38.84M-293.87%-19.93M-239.32%-17.28M
Income tax 20.00%30K-64.00%9K11K5K5K25K25K000
Net income 51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M-293.87%-19.93M-239.32%-17.28M
Net income continuous Operations 51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M-293.87%-19.93M-239.32%-17.28M
Minority interest income
Net income attributable to the parent company 51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M-293.87%-19.93M-239.32%-17.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M-293.87%-19.93M-239.32%-17.28M
Basic earnings per share 67.24%-1.3484.15%-0.1385.03%-0.2556.98%-0.372.70%-0.72-54.92%-4.09-97.76%-0.82-215.09%-1.6782.23%-0.86-231.73%-0.74
Diluted earnings per share 67.24%-1.3484.15%-0.1385.03%-0.2556.98%-0.372.70%-0.72-54.92%-4.09-97.76%-0.82-215.09%-1.6782.23%-0.86-231.73%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg